23andMe Research

By Christophe Tchakouté, 23andMe Biostatistician The number of weekly asthma attacks among people in the U.S. with active asthma increased by 10 percent in 2020 compared to the year before,...

As part of 23andMe’s ongoing effort to improve diversity in biomedical research, we recently began work on our Black Representation in Genetic Research study. This study aims to understand the...

February marks a time to remember and celebrate people of the African diaspora. To kick off a Black History Month of reflection, we’d like to highlight some of the projects...

23andMe Researchers analyzed weight measurements from 23andMe research participants in the weeks before, during, and after the Christmas holiday 2020. For many of us, holiday weight gain is just another...

A team of scientists at 23andMe created a new model to better estimate skin cancer risk, one of the most commonly diagnosed forms of cancer. Details of the new model...

In July, 23andMe launched a large-scale study of idiopathic pulmonary fibrosis (IPF), a serious disease that scars the lungs for reasons that scientists have yet to understand.23andMe currently has more...

By Eli Chanoff, 23andMe Research AssociateParkinson’s disease (PD) has been a central focus of 23andMe’s research since our company’s early years. Over more than a decade, we have grown a...

Even with promising COVID-19 vaccines on the horizon, it will likely be many months before they are widely available. This means that we must continue to do what we can...

Research shows that there really are “cat people” and “dog people.” Being one or the other is associated with differences in personality and well-being, according to new data analyzed by...

23andMe recently launched a genetic study of systemic sclerosis, a rare autoimmune disease that results in the hardening and thickening of the skin and other organs, for which there is...